Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Translational Lung Cancer Research|February 11, 2021
Induction treatment in patients with stage III non-small cell lung cancerRamón Palmero, Noelia Vilariño, Arturo Navarro-Martín, et al.Head & Neck Oncology|February 26, 2010
Rapid palliation of symptoms with platinum-based chemotherapy plus cetuximab in recurrent oral cancer: a case reportRicard Mesía, Ramón Palmero, Mònica Cos, et al.Acta Oto-Laryngologica|March 17, 2007
Expression of cyclooxygenase-2 mRNA in peripheral blood of head and neck cancer patients and in healthy controls. A pilot studyJuan J Grau, Mariano Monzó, Miguel Caballero, et al.Molecular Oncology|November 9, 2023
Transcriptional analysis of landmark molecular pathways in lung adenocarcinoma results in a clinically relevant classification with potential therapeutic implicationsSara Hijazo-Pechero, Ania Alay, David Cordero, et al.Annals of Translational Medicine|May 14, 2021
Perilesional edema in brain metastases as predictive factor of response to systemic therapy in non-small cell lung cancer patients: a preliminary studyMontse Alemany, Marta Domènech, Andreas A Argyriou, et al.Endocrine|February 27, 2019
Thyroid dysfunction induced by nivolumab: searching for disease patterns and outcomesInmaculada Peiró, Ramón Palmero, Pedro Iglesias, et al.Lung Cancer (Amsterdam, Netherlands)|March 1, 2011
Phase I study of concurrent chemoradiation with pemetrexed and cisplatin followed by consolidation pemetrexed for patients with unresectable stage III non-small cell lung cancerFelipe Cardenal, María Dolores Arnaiz, Teresa Morán, et al.Anti-Cancer Drugs|December 17, 2020
Duloxetine against symptomatic chemotherapy-induced peripheral neurotoxicity in cancer survivors: a real world, open-label experienceRoser Velasco, Sarah Besora, Andreas A Argyriou, et al.Lung Cancer (Amsterdam, Netherlands)|June 20, 2017
A phase Ib trial of continuous once-daily oral afatinib plus sirolimus in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer and/or disease progression following prior erlotinib or gefitinibTeresa Moran, Ramón Palmero, Mariano Provencio, et al.Journal for Immunotherapy of Cancer|February 26, 2021
Integrative transcriptome analysis of malignant pleural mesothelioma reveals a clinically relevant immune-based classificationAnia Alay, David Cordero, Sara Hijazo-Pechero, et al.Pageof 3